Referred to the House Committee on Ways and Means.
This bill (WEAR IT Act) amends the Internal Revenue Code to allow certain wearable devices, including associated software and subscriptions, to be treated as qualified medical expenses for Health Savings Accounts (HSAs), Archer MSAs, health flexible spending arrangements (HFSAs), and health reimbursement arrangements (HRAs). The law defines a "wearable device" as a device or software worn on the body (or used with a worn device) that collects/analyzes physiological data for diagnosis, treatment, prevention, or that assists in diagnosis or treatment.
Distributional impact: liberals worry HSAs primarily help higher-income people; conservatives emphasize consumer choice and market access.
Relative to its intended legislative type, this bill is a concise statutory amendment that clearly adds 'wearable devices' as a qualified medical expense under specific tax-advantaged accounts, with a defined annual dollar limit and explicit Code amendments and effective dates.
This bill (WEAR IT Act) amends the Internal Revenue Code to allow certain wearable devices, including associated software and subscriptions, to be treated as qualified medical expenses for Health Savings Accounts (HSAs), Archer MSAs, health flexible spending arrangements (HFSAs), and health reimbursement arrangements (HRAs).
The law defines a "wearable device" as a device or software worn on the body (or used with a worn device) that collects/analyzes physiological data for diagnosis, treatment, prevention, or that assists in diagnosis or treatment.
The change limits tax-advantaged spending or reimbursements for such devices to $375 per taxable year.
On content alone, this is a modest, administrable change with limited fiscal exposure and low ideological heat, which improves its prospects. However, as a small, discrete tax expenditure it lacks the urgency to move alone and would typically need to be attached to a larger tax/health package or appropriations vehicle to become law, creating additional political and procedural dependencies.
Relative to its intended legislative type, this bill is a concise statutory amendment that clearly adds 'wearable devices' as a qualified medical expense under specific tax-advantaged accounts, with a defined annual dollar limit and explicit Code amendments and effective dates.
Distributional impact: liberals worry HSAs primarily help higher-income people; conservatives emphasize consumer choice and market access.
These are examples from the analysis, not a ranked list of the most-affected groups.
Distributional impact: liberals worry HSAs primarily help higher-income people; conservatives emphasize consumer choice and market access.
A mainstream progressive would view the bill as a modest, targeted expansion of what counts as a medical expense under tax-advantaged accounts that could improve access to some health-monitoring tools.
They would generally welcome anything that helps preventative care and chronic-condition management, but be cautious because HSAs and related accounts disproportionately benefit higher-income and employer-covered individuals.
They would be concerned about subsidizing devices or services that lack robust clinical evidence, potential privacy/data-use issues, and the risk that these tax benefits widen health inequities.
A pragmatic moderate would likely view this as a small, low-cost expansion of allowable medical expenses that leans toward consumer choice and modernization of tax-advantaged accounts.
They would appreciate the modest $375 cap as fiscally constrained and see potential preventive health gains, but want clarity on which devices qualify and guardrails to prevent misuse.
They would weigh the administrative feasibility for plan administrators and favor oversight or reporting requirements to monitor effectiveness and fiscal impact.
A mainstream conservative would generally favor the bill as a consumer-driven, market-friendly expansion that allows pre-tax dollars to follow individuals seeking to manage their own health.
They would like that it expands choice without creating a large new federal program or mandatory spending, and that the $375 cap limits fiscal exposure.
Their primary concerns would be minimizing regulatory mandates or employer burdens and ensuring the change does not create unintended liabilities for plan sponsors.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, this is a modest, administrable change with limited fiscal exposure and low ideological heat, which improves its prospects. However, as a small, discrete tax expenditure it lacks the urgency to move alone and would typically need to be attached to a larger tax/health package or appropriations vehicle to become law, creating additional political and procedural dependencies.
The bill has not accumulated any surfaced votes yet.
Distributional impact: liberals worry HSAs primarily help higher-income people; conservatives emphasize consumer choice and market access.
On content alone, this is a modest, administrable change with limited fiscal exposure and low ideological heat, which improves its prospect…
Relative to its intended legislative type, this bill is a concise statutory amendment that clearly adds 'wearable devices' as a qualified medical expense under specific tax-advantaged accounts, with a defined annual dol…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.